1-20 of 759 Search Results for

prescription

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Article
Journal of Health Politics, Policy and Law (1 April 1998) 23 (2): 395–396.
Published: 01 April 1998
...Peter Temin Peter Davis, ed. Contested Ground: Public Purpose and Private Interest in the Regulation of Prescription Drugs. New York: Oxford University Press, 1996. 262 pp. $39.95 cloth. Copyright © 1998 by Duke University Press 1998 Reviews...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1984) 9 (3): 527–529.
Published: 01 June 1984
...Ronald C. Lippincott Henry J. Aaron and William B. Schwartz, The Painful Prescription: Rationing Hospital Care (Washington, D.C.: The Brookings Institution, 1984), 161 pp., $22.95 Copyright © 1984 by the Department of Health Administration, Duke University 1984 Henry J. Aaron and...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1994) 19 (4): 919–921.
Published: 01 August 1994
...Mark A. Hall Paul Jesilow, Henry N. Pontell, and Gilbert Geis. Prescription for Profit: How Doctors Defraud Medicaid . Berkeley, CA: University of California Press, 1993. 218 pp. $25.00 cloth. Copyright © 1994 by Duke University Press 1994...
Journal Article
Journal of Health Politics, Policy and Law (1 August 1994) 19 (4): 922–924.
Published: 01 August 1994
...Kenneth I. Kaitin Milton Silverman, Mia Lydecker, and Philip R. Lee. Bad Medicine: The Prescription Drug Industry in the Third World . Stanford, CA: Stanford University Press, 1992. 358 pp. $29.95 cloth. Copyright © 1994 by Duke University Press 1994 922 Journal of Health Politics...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2000) 25 (5): 815–844.
Published: 01 October 2000
...Robin D. C. Gauld This article discusses events that led up to and the aftermath of New Zealand's radical health sector restructuring of 1993. It suggests that“big bang” policy change facilitated the introduction of a set of market-oriented ideas describable as a policy prescription. In general...
Journal Article
Journal of Health Politics, Policy and Law (1 June 2013) 38 (3): 475–477.
Published: 01 June 2013
... . www.nytimes.com/roomfordebate/2012/02/15/how-to-curb-prescription-drug-abuse . Sabet Kevin A. 2012 . “How to Treat the Epidemic.” New York Times , February 15 . www.nytimes.com/roomfordebate/2012/02/15/how-to-curb-prescription-drug-abuse/how-to-treat-the-prescription-drug-epidemic...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2019) 44 (1): 157–164.
Published: 01 February 2019
...Scott L. Greer Ezekiel J. Emanuel . Prescription for the Future: The Twelve Transformational Practices of Highly Effective Medical Organizations . New York : PublicAffairs , 2017 . 272 pages. $18.99 cloth. Copyright © 2019 by Duke University Press 2019 Ezekiel J. Emanuel has...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2007) 32 (2): 187–219.
Published: 01 April 2007
...Jonathan Oberlander The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) represents a watershed event in Medicare politics. This essay explores the political lessons and policy legacies of the MMA, focusing on how the MMA fits with and deviates from established patterns in...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2008) 33 (6): 1079–1106.
Published: 01 December 2008
...Austin B. Frakt; Steven D. Pizer; Ann M. Hendricks Medicare and the Veterans Health Administration (VA) both finance large outpatient prescription drug programs, though in very different ways. In the ongoing debate on how to control Medicare spending, some suggest that Medicare should negotiate...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2011) 36 (2): 295–316.
Published: 01 April 2011
...Patricia M. Danzon; Scott J. Johnson; Genia Long; Michael F. Furukawa The option of legalizing the commercial importation of prescription drugs is of continued policy interest as a way to reduce U.S. drug spending. Using IMS data, we estimate potential savings from commercial drug importation under...
Journal Article
Journal of Health Politics, Policy and Law (1 October 2010) 35 (5): 705–742.
Published: 01 October 2010
... outpatient prescription drugs is not. To solve problems of access, Canadian provinces have introduced provincial prescription drug benefit programs. This study analyzes the prescription drug policymaking process in five Canadian provinces between 1992 and 2004 with a view to (1) determining the federal...
Journal Article
Journal of Health Politics, Policy and Law (1 April 2014) 39 (2): 295–330.
Published: 01 April 2014
...Jamie R. Daw; Steven G. Morgan; Patricia A. Collins; Julia Abelson Abstract Canada is the only country in the world to offer universal comprehensive public health insurance that excludes outpatient prescription medicines. Few scholars have attempted to explain this policy puzzle. We study media...
Journal Article
Journal of Health Politics, Policy and Law (1 February 2007) 32 (1): 89–129.
Published: 01 February 2007
...Virginia Gray; David Lowery; Erik K. Godwin While Congress debated prescription drug coverage for more than a decade before amending the Medicare program in 2003, thirty-one states provided such benefits to their citizens. Why were the same special interests that were reputedly so effective in...
Journal Article
Journal of Health Politics, Policy and Law (1 June 1979) 4 (3): 382–413.
Published: 01 June 1979
...James F. Blumstein; Michael Zubkoff Development of health policy goals necessitates a choice among normative premises—an accommodation of conflicting values. Any debate that does not identify underlying assumptions or link policy prescriptions to a theoretical perspective is destined to degenerate...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2010) 35 (6): 961–997.
Published: 01 December 2010
...Thomas Rice; Janet Cummings The Medicare prescription drug benefit relies on private insurers. In most states, there are nearly fifty competing insurance plans available. The sheer number of choices makes it extremely difficult for Medicare beneficiaries, many of whom must cope with declining...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2002) 27 (6): 889–926.
Published: 01 December 2002
... failures to implement demonstration projects intended to test competitive pricing within the Medicare program, and (3) the inability of state regulations to assuage the public's concerns about managed care. Some prescriptions for a more revealing and effective treatment of market reforms in health policy...
Journal Article
Journal of Health Politics, Policy and Law (1 December 2004) 29 (6): 1187–1226.
Published: 01 December 2004
... results compare to those that may occur under the premium support demonstration project,beginning in 2010, established under the Medicare Prescription Drug,Improvement, and Modernization Act of 2003. © 2004 by Duke University Press 2004 Aaron, H. J., and R. D. Reischauer. 1995 . The Medicare...
Journal Article
Journal of Health Politics, Policy and Law (1 August 2005) 30 (4): 719–750.
Published: 01 August 2005
...Helene Levens Lipton; Jonathan D. Agnew; Marilyn R. Stebbins; Angela Kuo; R. Adams Dudley As drug costs rose in the 1990s, health maintenance organizations (HMOs) began transferring risk for prescription drug expenditures to physician groups. With principal-agent theory as a framework for...
Journal Article
Journal of Health Politics, Policy and Law (1 April 1981) 6 (2): 188–204.
Published: 01 April 1981
... prescriptions for possible change. It suggests that current attempts to restrain spending through planning mechanisms will fail unless there are matching financial mechanisms of control, and unless ways are devised of overcoming the resistance of the constituencies for the status quo. Copyright © 1981 by the...
Journal Article
Journal of Health Politics, Policy and Law (1 April 1982) 7 (2): 488–501.
Published: 01 April 1982
...Andrew Dunham; James A. Morone; William White Competition has become a popular prescription for the problem of rising health costs. One issue largely absent from discussions of market systems and medicine, however, has been analysis of the implications for the poor. This paper explores the...